516 related articles for article (PubMed ID: 24980759)
21. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
[TBL] [Abstract][Full Text] [Related]
22. Fibroblasts weaken the anti-tumor effect of gefitinib on co-cultured non-small cell lung cancer cells.
Yong X; Wang P; Jiang T; Yu W; Shang Y; Han Y; Zhang P; Li Q
Chin Med J (Engl); 2014; 127(11):2091-6. PubMed ID: 24890158
[TBL] [Abstract][Full Text] [Related]
23. CDH1 and IL1-beta expression dictates FAK and MAPKK-dependent cross-talk between cancer cells and human mesenchymal stem cells.
Al-toub M; Vishnubalaji R; Hamam R; Kassem M; Aldahmash A; Alajez NM
Stem Cell Res Ther; 2015 Jul; 6(1):135. PubMed ID: 26204886
[TBL] [Abstract][Full Text] [Related]
24. Mature adipocytes, but not preadipocytes, promote the growth of breast carcinoma cells in collagen gel matrix culture through cancer-stromal cell interactions.
Manabe Y; Toda S; Miyazaki K; Sugihara H
J Pathol; 2003 Oct; 201(2):221-8. PubMed ID: 14517839
[TBL] [Abstract][Full Text] [Related]
25. Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer.
West NR; Murray JI; Watson PH
Oncogene; 2014 Mar; 33(12):1485-94. PubMed ID: 23584474
[TBL] [Abstract][Full Text] [Related]
26. Endoplasmic reticulum protein 29 regulates epithelial cell integrity during the mesenchymal-epithelial transition in breast cancer cells.
Bambang IF; Lee YK; Richardson DR; Zhang D
Oncogene; 2013 Mar; 32(10):1240-51. PubMed ID: 22543584
[TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
28. Fibroblasts induce epithelial to mesenchymal transition in breast tumor cells which is prevented by fibroblasts treatment with histamine in high concentration.
Porretti JC; Mohamad NA; Martín GA; Cricco GP
Int J Biochem Cell Biol; 2014 Jun; 51():29-38. PubMed ID: 24685678
[TBL] [Abstract][Full Text] [Related]
29. The effect of atp-dependent potassium uptake on mitochondrial functions under acute hypoxia.
Akopova O; Nosar V; Gavenauskas B; Bratus L; Kolchinskaya L; Mankovska I; Sagach V
J Bioenerg Biomembr; 2016 Feb; 48(1):67-75. PubMed ID: 26739597
[TBL] [Abstract][Full Text] [Related]
30. [Translational medicine in Russian cardiology: a new stage or repetition of the past?].
Tereshchenko SN; Zhirov IV; Kochetov AG
Ter Arkh; 2016; 88(9):5-9. PubMed ID: 27735907
[TBL] [Abstract][Full Text] [Related]
31. Association of polymorphic G1934A variant (allele *4) of CYP2D6 gene with increased risk of breast cancer development in Ukrainian women.
Levkovich NN; Gorovenko NG; Myasoedov DV
Exp Oncol; 2011 Sep; 33(3):136-9. PubMed ID: 21956465
[TBL] [Abstract][Full Text] [Related]
32. Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.
Chen SC; Kung ML; Hu TH; Chen HY; Wu JC; Kuo HM; Tsai HE; Lin YW; Wen ZH; Liu JK; Yeh MH; Tai MH
J Pathol; 2012 Oct; 228(2):158-69. PubMed ID: 22247069
[TBL] [Abstract][Full Text] [Related]
33. Sustained co-cultivation with human placenta-derived MSCs enhances ALK5/Smad3 signaling in human breast epithelial cells, leading to EMT and differentiation.
Yoo YA; Kang MH; Kim BS; Kim JS; Seo JH
Differentiation; 2009 Jun; 77(5):450-61. PubMed ID: 19375841
[TBL] [Abstract][Full Text] [Related]
34. Human lung cancer-associated fibroblasts enhance motility of non-small cell lung cancer cells in co-culture.
Kim SH; Choe C; Shin YS; Jeon MJ; Choi SJ; Lee J; Bae GY; Cha HJ; Kim J
Anticancer Res; 2013 May; 33(5):2001-9. PubMed ID: 23645749
[TBL] [Abstract][Full Text] [Related]
35. Induction of epithelial to mesenchymal transition in PMC42-LA human breast carcinoma cells by carcinoma-associated fibroblast secreted factors.
Lebret SC; Newgreen DF; Thompson EW; Ackland ML
Breast Cancer Res; 2007; 9(1):R19. PubMed ID: 17311675
[TBL] [Abstract][Full Text] [Related]
36. Effect of truncated neurokinin-1 receptor expression changes on the interaction between human breast cancer and bone marrow-derived mesenchymal stem cells.
Zhou Y; Zuo D; Wang M; Zhang Y; Yu M; Yang J; Yao Z
Genes Cells; 2014 Sep; 19(9):676-91. PubMed ID: 25130457
[TBL] [Abstract][Full Text] [Related]
37. Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial-mesenchymal transition.
Sultan AS; Brim H; Sherif ZA
Cancer Sci; 2008 Feb; 99(2):272-9. PubMed ID: 18271926
[TBL] [Abstract][Full Text] [Related]
38. Tumor tissue inhibitor of metalloproteinases-1 (TIMP-1) in hormone-independent breast cancer might originate in stromal cells, and improves stratification of prognosis together with nodal status.
Kuvaja P; Hulkkonen S; Pasanen I; Soini Y; Lehtonen S; Talvensaari-Mattila A; Pääkkö P; Kaakinen M; Autio-Harmainen H; Hurskainen T; Lehenkari P; Turpeenniemi-Hujanen T
Exp Cell Res; 2012 Jun; 318(10):1094-103. PubMed ID: 22465225
[TBL] [Abstract][Full Text] [Related]
39. Tumor-stromal interactions with direct cell contacts enhance motility of non-small cell lung cancer cells through the hedgehog signaling pathway.
Choe C; Shin YS; Kim SH; Jeon MJ; Choi SJ; Lee J; Kim J
Anticancer Res; 2013 Sep; 33(9):3715-23. PubMed ID: 24023301
[TBL] [Abstract][Full Text] [Related]
40. Activation of IGF/IGF-IR signaling pathway fails to induce epithelial-mesenchymal transition in pancreatic cancer cells.
Kopantzev EP; Kopantseva MR; Grankina EV; Mikaelyan A; Egorov VI; Sverdlov ED
Pancreatology; 2019 Mar; 19(2):390-396. PubMed ID: 30799278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
